Table of Content

  1. Introduction
    • Definition of Endometrial Cancer Market
    • Scope of the Report
  2. Methodology
    • Executive Summary
    • Market Overview
    • Market Definition and Segmentation
  3. Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
    • Porter's Five Forces Analysis
    • PESTEL Analysis
  4. Endometrial Cancer Market, By Diagnosis:
    • Pelvic examination
    • Transvaginal ultrasound
    • Endometrial biopsy
    • Dilation and curettage (D&C)
    • Diagnostic laparoscopy
  5. Endometrial Cancer Market, By Treatment:
    • Hysterectomy Techniques
      • Open abdominal hysterectomy
      • Total vaginal hysterectomy
      • Total laparoscopic hysterectomy
      • Robotic hysterectomy
    • Radiation
      • External radiation
      • Internal radiation (brachytherapy)
    • Hormone therapy
      • Progestins
      • Tamoxifen
      • Luteinizing hormone-releasing hormone agonists
      • Aromatase inhibitors
    • Chemotherapy
      • Paclitaxel
      • Carboplatin
      • Doxorubicin
      • Cisplatin
    • Palliative care
  6. Endometrial Cancer Market, By End-User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • GynecologyCenters
    • Feminist Health Centers
  7. Endometrial Cancer Market, By Geography
    • North America
      • United States
      • Canada
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • Saudi Arabia
      • United Arab Emirates
      • South Africa
      • Rest of Middle East & Africa
  8. Competitive Landscape
  9. Company Profiles
    • Pfizer Inc.
      • Company Overview
      • Product Portfolio and Description
      • Key Highlights
      • Financial Overview
    • General Electric Company
    • Koninklijke Philips N.V.
    • LUPIN, PHYTON
    • Bayer AG
    • Celgene Corporation
    • Johnson & Johnson
    • CooperSurgical Inc.
    • LiNA Medical USA
    • Conceptus Inc.
    • Hologic Inc.
    • Karl Storz GmbH & Co. Kg,
    • Boston Scientific Corporation
  10. Conclusion and Future Outlook
  11. Appendix
    • Research Methodology
    • About the Pharmanucleus
  12. Disclaimer


Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.